Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint=false, and the description does not contradict them. It adds significant behavioral detail beyond annotations: graceful degradation when GLEIF/OpenFIGI is unavailable, explicit unresolved identifiers, returning figi_candidates on ambiguity, source labeling, and internal cascading across lookup endpoints.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense and long, but nearly every sentence carries operational value—usage directives, supported types, ambiguity handling, degradation behavior, and input caveats are all included. It is front-loaded with 'Use FIRST' and the core purpose. Slight verbosity in phrases like 'cross-source identity spine' keeps it from a perfect score.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite no output schema, the description thoroughly explains return contents: CIK, ticker, company_name, LEI, FIGI, RxCUI, ingredient, brand, citation, source labels, unresolved identifiers, and figi_candidates. It also covers input formats, edge cases like non-US issuers and non-equity instruments, and failure behavior. An agent has everything needed to call it correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although schema coverage is 100%, the description adds meaning well beyond the schema: it explains the 'value' parameter must be the entity name only, warns that trailing security-class words like 'revenue bonds' will fail FIGI matching, and gives concrete examples for both company and drug types. This materially improves an agent's ability to construct correct calls.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb and resource: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It includes concrete query examples, names the supported entity types, and explicitly positions itself as the first step when an ID is needed, distinguishing it from sibling tools like entity_profile and search_within.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit context: 'Use FIRST whenever you have a name but need an ID.' It also clarifies scope by saying it 'replaces 2-3 manual lookups' and describes what inputs are accepted. It does not explicitly exclude alternatives like entity_profile or compare_entities, but the 'Use FIRST' directive provides clear routing guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4/5.0
Disambiguation3/5

Most tools have highly detailed descriptions that clarify their distinct roles, and the pipeworx/boi/polymarket families are individually distinguishable. However, ask_pipeworx_beta is explicitly described as currently identical to ask_pipeworx (a true duplicate), and the polymarket tools (arbitrage, edges, edge_tracker, fill_risk, kalshi_spread) share overlapping purpose and could cause misselection despite their lengthy docs.

Naming Consistency3/5

Many tools follow a clear verb_noun pattern (compare_entities, discover_tools, resolve_entity, validate_claim), but a large subset uses noun-first or prefixed compound names (ai_visibility_check, bet_research, boi_exchange_rate, polymarket_arbitrage). The naming is readable and group-consistent (boi_*, polymarket_*, ask_pipeworx*) but the overall convention is mixed rather than uniform.

Tool Count2/5

At 34 tools, the set exceeds the 25+ threshold for 'too many' and spans many unrelated domains (data lookup, prediction markets, memory, subscriptions, AI visibility, llms.txt generation, feedback). The broad scope explains the count, but many tools feel like add-on utilities rather than a tightly scoped server, making the surface feel bloated.

Completeness4/5

The core domain—authoritative structured data access—is extremely well covered: universal routing, grounded mode, deep research, entity profiles, comparisons, claim validation, resolution, discovery, and suggestions. Minor gaps exist (no explicit tool for fetching a pipeworx:// citation URI directly, no update operation for subscriptions), but agents can work around these via the router and existing subscription lifecycle tools.